Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Wieder

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Cancers|April 13, 2023
Fibroblasts as Turned Agents in Cancer ProgressionRobert Wieder
Methods in Molecular Biology (Clifton, N.J.)|July 22, 2024
Bone Marrow Stroma Co-cultivation Model of Breast Cancer DormancyRobert Wieder
Cancers|June 10, 2023
Awakening of Dormant Breast Cancer Cells in the Bone MarrowRobert Wieder
Methods in Molecular Medicine|May 25, 2005
TUNEL assay as a measure of chemotherapy-induced apoptosisRobert Wieder
Cancers|July 27, 2022
Stromal Co-Cultivation for Modeling Breast Cancer Dormancy in the Bone MarrowRobert Wieder
Biomedicines|June 27, 2024
Temporal Association Rule Mining: Race-Based Patterns of Treatment-Adverse Events in Breast Cancer Patients Using SEER-Medicare DatasetNabil Adam, Robert Wieder
Cancers|July 13, 2024
Correction: Wieder, R.; Adam, N. Racial Disparities in Breast Cancer Treatments and Adverse Events in the SEER-Medicare Data. <i>Cancers</i> 2023, <i>15</i>, 4333Robert Wieder, Nabil Adam
Oncogene|January 16, 2004
All-trans retinoic acid potentiates Taxotere-induced cell death mediated by Jun N-terminal kinase in breast cancer cellsQin Wang, Robert Wieder
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|March 25, 2009
Dual FGF-2 and intergrin alpha5beta1 signaling mediate GRAF-induced RhoA inactivation in a model of breast cancer dormancyJudith Barrios, Robert Wieder
Critical Reviews in Oncology/Hematology|June 2, 2022
Drug repositioning for cancer in the era of AI, big omics, and real-world dataRobert Wieder, Nabil Adam
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Cancers|April 13, 2023
Fibroblasts as Turned Agents in Cancer ProgressionRobert Wieder
Methods in Molecular Biology (Clifton, N.J.)|July 22, 2024
Bone Marrow Stroma Co-cultivation Model of Breast Cancer DormancyRobert Wieder
Cancers|June 10, 2023
Awakening of Dormant Breast Cancer Cells in the Bone MarrowRobert Wieder
Methods in Molecular Medicine|May 25, 2005
TUNEL assay as a measure of chemotherapy-induced apoptosisRobert Wieder
Cancers|July 27, 2022
Stromal Co-Cultivation for Modeling Breast Cancer Dormancy in the Bone MarrowRobert Wieder
Biomedicines|June 27, 2024
Temporal Association Rule Mining: Race-Based Patterns of Treatment-Adverse Events in Breast Cancer Patients Using SEER-Medicare DatasetNabil Adam, Robert Wieder
Cancers|July 13, 2024
Correction: Wieder, R.; Adam, N. Racial Disparities in Breast Cancer Treatments and Adverse Events in the SEER-Medicare Data. <i>Cancers</i> 2023, <i>15</i>, 4333Robert Wieder, Nabil Adam
Oncogene|January 16, 2004
All-trans retinoic acid potentiates Taxotere-induced cell death mediated by Jun N-terminal kinase in breast cancer cellsQin Wang, Robert Wieder
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|March 25, 2009
Dual FGF-2 and intergrin alpha5beta1 signaling mediate GRAF-induced RhoA inactivation in a model of breast cancer dormancyJudith Barrios, Robert Wieder
Critical Reviews in Oncology/Hematology|June 2, 2022
Drug repositioning for cancer in the era of AI, big omics, and real-world dataRobert Wieder, Nabil Adam
Pageof 4